[BMJ发表论文]:脑局部组织氧饱和度指导早产儿氧输送治疗已关闭评论
Research
Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial
Gerhard Pichler, Katharina Goeral, Marlene Hammerl, et al
BMJ 2023; 380 doi: https://doi.org/10.1136/bmj-2022-072313 (Published 24 January 2023)Cite this as: BMJ 2023;380:e072313
Abstract
Objective To investigate whether monitoring of cerebral tissue oxygen s...
阅读全文
[BMJ发表文章]:新冠病毒感染的症状如何改变?已关闭评论
Feature Covid Unanswered Questions
How are covid-19 symptoms changing?
Mun-Keat Looi
BMJ 2023; 380 doi: https://doi.org/10.1136/bmj.p3 (Published 18 January 2023)Cite this as: BMJ 2023;380:p3
With new variants and a changing landscape of vaccination and immunity, what do the symptoms of covid-19—and our understanding of them—now look like? Mun-Keat Looireports
How have covid symptoms changed since the start of the pandemic?
In the short space o...
阅读全文
[Clin Infect Dis发表论文]:成人多系统炎症综合征已关闭评论
Multisystem Inflammatory Syndrome in Adults: Case Finding Through Systematic Review of Electronic Medical Records
Michael Melgar, Julia Haston, Jennifer DeCuir, et al
Clinical Infectious Diseases, Volume 75, Issue 11, 1 December 2022, Pages 1903–1911, https://doi.org/10.1093/cid/ciac303
Abstract
Background
Multisystem inflammatory syndrome in adults (MIS-A) is a severe condition temporally associated with severe acute respiratory syndrome coronavir...
阅读全文
[JAMA发表述评]:TRANSFORM-HF:有关利尿剂治疗心衰能否形成闭环?已关闭评论
Editorial
January 17, 2023
TRANSFORM-HF—Can We Close the Loop on Diuretics in Heart Failure?
Michelle M. Kittleson
JAMA. 2023;329(3):211-213. doi:10.1001/jama.2022.21692
Fluid overload is the cardinal manifestation of heart failure, and prior to the 20th century, treatment options were limited to purgatives, bloodletting, leeching, or lancing. It was not until 1920 that the concept of a diuretic was first appreciated, when physicians observe...
阅读全文
[NEJM发表论文]:严重甲型血友病患者的Efanesoctocog Alfa预防已关闭评论
ORIGINAL ARTICLE
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
Annette von Drygalski, Pratima Chowdary, Roshni Kulkarni, et al
N Engl J Med 2023; 388:310-318DOI: 10.1056/NEJMoa2209226
Abstract
BACKGROUND
Efanesoctocog alfa provides high sustained factor VIII activity by overcoming the von Willebrand factor–imposed half-life ceiling. The efficacy, safety, and pharmacokinetics of efanesoctocog alfa for prophylaxis and treatment of bl...
阅读全文
[Lancet发表述评]:新冠病毒感染,再次感染以及向地方病的转变已关闭评论
COMMENT|ONLINE FIRST
COVID-19 infection, reinfection, and the transition to endemicity
Cheryl Cohen, Juliet Pulliam
Lancet Published: February 16, 2023
DOI:https://doi.org/10.1016/S0140-6736(22)02634-4
Understanding the protection conferred by previous infection against repeat infection, illness, and severe disease is key to projecting the future epidemiology of COVID-19 and to guiding vaccine policy decisions. In The Lancet, The COVID-19 Forecasting Team1 ...
阅读全文
[NEJM发表论文]:不含有种族和性别的胱抑素C公式估算GFR已关闭评论
ORIGINAL ARTICLE
Cystatin C–Based Equation to Estimate GFR without the Inclusion of Race and Sex
Hans Pottel, Jonas Björk, Andrew D. Rule, et al
N Engl J Med 2023; 388:333-343DOI: 10.1056/NEJMoa2203769
Abstract
BACKGROUND
The accuracy of estimation of kidney function with the use of routine metabolic tests, such as measurement of the serum creatinine level, has been controversial. The European Kidney Function Consortium (EKFC) developed a creatinine-base...
阅读全文
[Lancet发表论文]:既往新冠病毒感染对再次感染的保护作用已关闭评论
ARTICLES|ONLINE FIRST
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
COVID-19 Forecasting Team
Lancet Published: February 16, 2023
DOI:https://doi.org/10.1016/S0140-6736(22)02465-5
Summary
Background
Understanding the level and characteristics of protection from past SARS-CoV-2 infection against subsequent re-infection, symptomatic COVID-19 disease, and severe disease is essential for predicting future...
阅读全文
[JAMA医学新闻]:免疫功能抑制人群新冠病毒感染指导意见更新已关闭评论
Medical News in Brief
February 8, 2023
Updated COVID-19 Guidance for People Who Are Immunocompromised
Emily Harris
JAMA. Published online February 8, 2023. doi:10.1001/jama.2023.1176
In late January, the US Food and Drug Administration announced that Evusheld (the combined monoclonal antibodies tixagevimab and cilgavimab) is not currently authorized for emergency use because it’s likely ineffective against more than 90% o...
阅读全文
[Lancet Respir Med发表论文]:接受机械通气的新冠肺炎相关ARDS患者的呼吸力学、气体交换和预后已关闭评论
REVIEW| VOLUME 10, ISSUE 12, P1178-1188, DECEMBER 01, 2022
Respiratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis
Mallikarjuna Ponnapa Reddy, Ashwin Subramaniam, Clara ChuaRyan Ruiyang Ling et al.
Lancet Respir Med 2022; 10: 1178-1188 Published:November 03, 2022
DOI:https://doi.org/10.1016/S2213-2600(22)00393-9
...
阅读全文